HAI2026 · 18th Edition

2026 Poster Sessions

January 12–14, 2026 · Puerto Rico Convention Center, San Juan, Puerto Rico. All accepted poster abstracts presented across six sessions over three days.

Poster Sessions

110+

Posters Presented

Days

100%

Peer Reviewed

Click any session to expand and view its posters

↕

Sort columns by clicking Board #, Title, Authors, or Presenter

🔍

Search within each session using the search field at top right of each table

POSTER SESSIONS: 1A - Monday, January 12 - 10:30 am - 11:30 pm; 1B - Monday, January 12, 4:20 - 5:20 pm

Board #	Title	Authors	Presenter
01	Longitudinal harmonization effects on tau-PET SUVRs trajectories in ADNI study	Ren \| Luo \| Laymon \| Minhas \| Cohen \| Wu \| Tudorascu	Ren, Yuxin
02	Integrating digital cognitive metrics with PET biomarkers to identify individuals at imminent risk of tau accumulation	Fu \| Robinson \| Farrell \| Jutten \| Thibault \| Thompson \| Tiss \| Chen \| Becker \| Healy \| Penney \| Davis \| Sperling \| Price \| Rentz \| Johnson	Fu, Jessie Fang-Lu
03	Amyloid-induced neuronal hyperactivity and metabolism are associated with faster tau accumulation in Alzheimer’s Disease	Roemer-Cassiano \| Zhang \| Evangelista \| Klonowski \| Hirsch \| Frontzkowski \| Steward \| Dewenter \| Biel \| Zhu \| Gnoerich \| Jaekel \| Hoeglinger \| Brendel \| Yeo \| Franzmeier	Roemer-Cassiano, Sebastian
04	Sex differences in white matter microstructure and associations with amyloid and tau pathology in autosomal dominant Alzheimer's disease	Giudicessi \| Koops, PhD \| Baena \| Alvarez \| Vidal \| Martinez \| Gonzalez \| Tristão-Pereira \| Malotaux \| He \| Aguillon \| Jacobs \| Cronin-Golomb \| Quiroz	Giudicessi, Averi
05	Concordance between amyloid PET and biomarkers of Alzheimer’s disease in plasma and cerebrospinal fluid in cognitively unimpaired individuals	Bermudez \| Fought \| Hofrenning \| Lowe \| Petersen \| Vemuri \| Jack, Jr. \| Algeciral-Schimnich \| Bornhorst \| Graff-Radford	Bermudez, Camilo
06	Comparing performance of different amyloid PET markers of spatial extent in their ability to predict future amyloid conversion	Honhar \| Farrell \| Properzi \| Thibault \| Schultz \| Becker \| Fu \| Sperling \| Price \| Johnson	Honhar, Praveen
07	Elevated ptau217 is more strongly associated with tau accumulation and cognitive decline in younger adults	Coughlan \| Townsend \| Li \| Seto \| Birkenbihl \| Cody \| Klinger \| Healy \| Farrell \| Thibault \| Rissman \| Properzi \| Schultz \| Chhatwal \| Yang \| Donohue \| Betthauser \| Johnson \| Johnson \| Sperling \| Buckley	Cuppels, Madison
08	Quantitative relationship between Lumipulse G measures of pTau217 in plasma and in brain	Vandenberghe \| Tomé \| De Meyer \| Goossens \| Lambrechts \| Poesen \| Vanbrabant \| Vanmechelen \| Thal	Thal, Dietmar
09	Distinct mechanisms underlying APOE-ε4 and sex effects on medial temporal tau pathology: A neuropathology study	Salvadó \| Groot \| Wisse \| Vogel \| Beach \| Serrano \| Reiman \| Schneider \| Bennett \| Ossenkoppele \| Hansson	Salvadó, Gemma
10	Harmonizing amyloid PET tracers at the regional level: evaluation of regional centiloid equations	Silvestri \| Chaggar \| Gobbi \| Aldea \| Klein \| Tonietto	Tonietto, Matteo
11	A case series of lecanemab treatment response in patients across the clinical phenotypic spectrum of AD	Corriveau-Lecavalier \| Machulda \| Fields \| Boots \| Whitwell \| Day \| Aduen \| Frank \| Kremers \| Ramanan \| Graff-Radford \| Lowe \| Boeve \| Knopman \| Petersen \| Jack \| Stricker \| Jones	Corriveau-Lecavalier, Nick
12	Validation of a pseudo-reference region for [11C]-ER176 in healthy volunteers and Alzheimer’s disease patients	Finn \| Zanotti-Fregonara \| Yu \| Masdeu \| Pascual	Finn, Quentin
13	β-amyloid PET signal reduction is higher in regions with ARIA-E due to anti-amyloid therapy	Finn \| Pascual \| Toledo \| Schulz \| Masdeu	Finn, Quentin
14	Lifetime and 10-year absolute risk of cognitive impairment associated with amyloid PET severity: a retrospective, longitudinal cohort study	Hu \| Therneau \| Wiste \| Knopman \| Vemuri \| Graff-Radford \| Lowe \| Vassilaki \| Cogswell \| Schwarz \| Algeciras-Schimnich \| Petersen \| Jack Jr.	Hu, Mingzhao
15	Trajectory of neurodegeneration and brain aging in relation to amyloid timing and duration	Zhang \| Robb \| Erus \| Castellano \| Cui \| Cody \| Harrison \| Engelman \| Albert \| Resnick \| Sperling \| Bilgel \| Vardarajan \| Mayeux \| Risacher \| Arfanakis \| Tosun \| Habes \| Wang \| Toga \| Thompson \| Kukull \| Biber \| Landman \| Bendlin \| Johnson \| Schneider \| Barnes \| Bennett \| Saykin \| De Jager \| Menon \| Harrison \| Mormino \| Cuccaro \| Davatzikos \| Betthauser \| Archer \| Hohman \| Dumitrescu \| Koran	Zhang, Mengna
16	Associations between tau pathology and cortical microstructure are modulated by amyloid burden independent of cortical atrophy in cognitively unimpaired older adults	Vogt \| Koops \| Schultz \| Properzi \| Salat \| Pascual-Leone \| Huang \| Buckley \| Rentz \| Johnson \| Sperling \| Jacobs	Vogt, Nicholas
17	Predicting tau PET burden using brain-derived plasma p-tau measures in the British 1946 birth cohort	Schott \| Coath \| Wiltshire \| Brown \| Cash \| Whittington \| Heslegrave \| Zetterberg \| Keshavan	Schott, Jonathan
18	Association of combined cardiovascular risk factors and treatments with longitudinal amyloid and tau PET in cognitively normal older adults	Ourry \| Thériault-Dubé \| Breitner \| Poirier \| Villeneuve	Ourry, Valentin
19	Amyloid-pet substantiates clinical decision-making in real-life clinical settings in Brazil	Schaffer Aguzzoli \| Flach \| Alves Da Silva \| C.L Ferreira \| Povala \| Ferrari-Souza \| Bieger \| Teixeira Leffa \| Bellaver \| Guevara Werlang \| Teribele Venturin \| Wetters Portuguez \| Possa Marroni \| Irigoyen da Costa \| Bernardi Soder \| Sebastião Matushita \| Juarez Amorim \| Pasquotto Souza \| Dario Ramos \| Leite \| Hygino \| Amorim Nogueira \| Sturzeneker Tres \| Okada de Oliveira \| Moriguchi Jeckel \| Cortes Domingues \| Mosci \| Rosado de Castro \| Buchpiguel \| Paiva Proença Lobo Lopes \| Carvalho Campos Neto \| Figueiredo Balthazar \| Tovar Moll \| Martins Novaes Coutinho \| Pascoal \| Zimmer \| Schilling \| Costa da Costa	Schaffer Aguzzoli, Cristiano
20	Neuropathological validation of Tau-PET CenTauR units: Preliminary data from a multicenter study	Iaccarino \| Chiotis \| Grinberg \| Kotari \| La Joie \| Leuzy \| Lowe \| Lu \| Moscoso \| Nguyen \| Schwarz \| Seeley \| Jack \| Rabinovici \| Shcherbinin	La Joie, Renaud
21	Molecular evaluation of a tau-PET analog and pathological TAR DNA-binding protein 43 docking in a cellular model of frontotemporal lobar degeneration	Gatto \| Weissmann \| Salinas Castellanos \| Montes \| Uruk \| Youssef \| Reichard \| Josephs	Gatto, Rodolfo G.
22	Anterior cingulate sulcal pattern is associated with successful cognitive aging	Maboudian \| Kellerman \| Willbrand \| Pezzoli \| Weiner \| Jagust	Maboudian, Samira
23	Microstructural white matter injury mediates the association between vascular risk and plasma biomarkers: Preliminary findings from the Diverse VCID study	Lee \| Sapkota \| Rajan \| Jin \| Hinman \| Johnson \| Harvey \| Maillard \| Fornage \| DeCarli	Lee, Seunghoon
24	VeraBIND Tau: a novel plasma assay reflecting tau aggregation increases over time in individuals with positive tau-PET signal	Hanseeuw \| Quenon \| Bayart \| Salman \| Pak \| Shamsundar \| Soldo \| Iqbal	Hanseeuw, Bernard
25	Amyloid PET quantitation using skewness: Autopsy validation and test–retest performance	Tunali \| Iaccarino \| Wang \| Kennedy \| Lu \| Shcherbinin	Tunali, Ilke
26	Stratifying preclinical Alzheimer’s disease by hippocampal volume to detect concomitant LATE	Mundada \| Lyu \| Sadeghpour \| Brown \| McGrew \| Yushkevich \| Das \| Wolk	Mundada, Nidhi
27	Differential sensitivity of [¹⁸F]MK6240 and [¹⁸F]FTP to measure tau before and after anti-amyloid therapy	Deng \| Finn \| Pando \| Matutue \| Lussier \| Fortea \| Tudorascu \| Soleimani-Meigooni \| Lowe \| Oh \| Gordon \| Rosa-Neto \| Baker \| Pascoal \| Masdeu \| Pascual	Deng, Han
28	Development of a highly sensitive and automated immunoassay for Brain-Derived pTau-217: Analytical performance in human plasma samples	Ma \| Wang \| Danthanarayana \| Kim \| Ji \| Jhaveri \| Zhang \| Qiu \| Mudumba \| Luo	Ma, Xiao-Jun
29	Network-based mechanistic modeling of Alzheimer's disease for evaluating diverse therapeutic mechanisms of action	Wooten \| Stage \| Mazer \| Townsend \| Comley \| Guo	Wooten, Dustin
30	Neuroimaging compendium of microglia, amyloid, tau, and neurodegeneration across clinical variants of Alzheimer's disease	Houlihan \| Guzman \| Smith \| Sanchez \| Kreisl \| Cosentino \| Noble \| Lao	Houlihan, Hannah
31	Predictors of longitudinal atrophy across NIA-AA biological PET stages	Fonseca \| Maboudian \| Chao \| Jagust \| Harrison	Fonseca, Corrina
32	Effect of uptake time on [18F]-flutemetamol visual interpretation and Centiloid quantification	Bollack \| Buckley \| Schwarz \| Battle \| Smith \| Stromrud \| Hansson \| Palmqvist \| Matttsson-Carlgren \| La Joie \| Farrar	Bollack, Ariane
33	Episodic memory decline and tau biomarkers progress earlier along the amyloid timeline in Down syndrome compared to neurotypical adults	Zammit \| Bruzzone \| Morse \| Batchelar \| Bettcher \| McLachlan \| McVea \| Carey \| Tudorascu \| Hartley \| Clark \| Ances \| Caldwell \| Johnson \| Handen \| Head \| Mapstone \| Christian \| Investigators \| Betthauser	Zammit, Matt
34	Relationship between p-tau217 and PET in preclinical AD: The moderating effect of white matter hyperintensity	Moon \| Chen	Moon, Hasom
35	Systemic inflammation–tau interaction: Insights from CRP modulation of p-tau217 association with tau PET positivity	Monto \| Boots \| Zeng \| Farinas \| Sehrawat \| Saeed \| Cohen \| Reis \| Lopez \| Snitz \| Karikari	Monto, Abdul Razak
36	Examining elevated choroid plexus binding of tau PET tracers in aging and Alzheimer’s disease	Marin \| Wales \| Ruais \| Richard \| Hedden	Marin, Anna
37	The influence of β-amyloid on neuroinflammatory 11C-ER176 uptake in progressive apraxia of speech	Satoh \| Utianski \| Duffy \| Clark \| Botha \| Lowe \| Josephs \| Whitwell	Satoh, Ryota
38	Subtracting first principal component may improve detectability of subtle 4R tau signals in 18F flortaucipir tau PET imaging	Satoh \| Ali \| Clark \| Dickson \| Lowe \| Josephs \| Whitwell	Satoh, Ryota
39	OMG: a proteomic determinant of neurodegenerative resiliency	Duggan \| Oh \| Frank \| Gomez \| Zweibaum \| Cui \| Chen \| Surapaneni \| Blew \| Dark \| Joynes \| Kandala \| Bilgel \| Farinas \| Erus \| Tian \| Candia \| Pucha \| Landman \| Dumitrescu \| Hohman \| Lewis \| Moghekar \| Siavoshi \| Ali \| Liu \| Xu \| Western \| Kaneko \| Kato \| Furuichi \| Shibayama \| Katsuno \| Nishita \| Otsuka \| Gottesman \| Dammer \| Seyfried \| Levey \| Johnson \| Mormino \| Wagner \| Poston \| Kapogiannis \| Grams \| Bhargava \| Waga \| Davatzikos \| Resnick \| Ferrucci \| Bennett \| Cruchaga \| Wyss-Coray \| Kivimäki \| Coresh \| Walker	Duggan, Michael
40	Frequency and consequences of extreme PET based pathological profiles in preclinical Alzheimer’s disease	Medina Guerra \| Cody \| Young \| Sheng \| Sokolowski \| Younes \| Trelle \| Tosun \| Hohman \| Mormino	Medina Guerra, Lucah
41	Periventricular diffusivity moderates the relationship between astrocyte reactivity and amyloid deposition in non-demented older adults	Chen \| Wu \| Yang \| Gogola \| Luo \| Villemagne \| Laymon \| Lopresti \| Cohen \| Ikonomovic \| Snitz \| Wilckens \| Lopez \| Tudorascu \| Aizenstein \| Minhas	Chen, Chang-Le
42	Disentangling the effects of age and Alzheimer's disease pathology on longitudinal atrophy in cognitively normal older adults	Haque \| Fonseca \| Maboudian \| La Joie \| Jagust	Haque, Miraal
43	Stronger amyloid–tau coupling explains faster tau progression in early-onset Alzheimer’s disease	Franzmeier \| Frontzkowski \| Steward \| Klonowski \| Dewenter \| Hirsch \| Biel \| Zhu \| Gnörich \| Höglinger \| Brendel \| Roemer-Cassiano	Franzmeier, Nicolai
44	Harmonization methods to mitigate batch effects in blood biomarker analysis	Zhang \| Lukasewicz Ferreira \| Minhas \| Pascoal \| Zeng \| Karikari \| Cohen \| Tudorascu	Zhang, Vivian
45	IGFR1, but not BDNF, acts as a suppressive neuroprotective factor between astrogliosis and visuospatial function among non-demented individuals	Ramirez Tirado \| Cohen \| Lopresti \| Ikonomovic \| Gogola \| Matan \| Zeng \| Karikari \| Lopez \| Shaaban \| Villemagne	Cohen, Ann D
46	The relation of psychosocial coping mechanisms to ATN pathophysiology differ across demographics	Schatz \| Snitz \| Roush \| Lopresti \| Villemagne \| Lopez \| Williams \| Cohen	Cohen, Ann
47	Evaluation of the Clinical IMpact of Blood-Based Biomarker Assays on dementia specialists' decision-making (CIMBBBA): Preliminary report from a real-world dementia subspecialty clinic study	Eldaief \| Krahn \| Murdock \| Rezaii \| Chan \| Arnold \| Avetisyan \| Ramirez Gomez \| Gale \| McGinnis \| Dickerson	Eldaief, Mark
48	Dynamic interplay of vascular injury and inflammation on Alzheimer’s disease pathophysiology	Rusdi \| Kang \| Yin \| Gibson \| Rahmouni \| Benedet \| Zetterberg \| Blennow \| Karikari \| Ashton \| Black \| Rosa-Neto \| Goubran \| Ottoy	Ottoy, Julie

POSTER SESSIONS: 2A - Tuesday, January 13 - 09:50 - 10:50 am; 2B - Tuesday, January 13, 3:40 - 4:40 pm

Board #	Title	Authors	Presenter
49	CSF oligodendrocyte biomarkers are associated with amyloid burden in Alzheimer’s disease	Santos Machado \| De Bastiani \| Lebrun \| Povala \| Pola \| Vizlin-Hodzic \| Rosa-Neto \| Zimmer \| Blennow \| Zetterberg \| Benedet \| Ashton	Santos Machado, Luiza
50	Associations between systolic blood pressure and amyloid burden on cross-sectional inferior temporal tau across mid- to late-life	Yau \| Scott \| Palmgren \| Coughlan \| Kirn \| Properzi \| Schultz \| Ghosh \| Buckley \| Amariglio \| Rentz \| Johnson \| Sperling \| Beiser \| Seshadri \| Chhatwal	Yau, Wai-Ying Wendy
51	Associations of ER176 TSPO PET with blood-based AD and neuroinflammation biomarkers	Cogswell \| Lundt \| Ou \| Algeciras-Schimnich \| Zekeridou \| Lim \| Graff-Radford \| Schwarz \| Vemuri \| Petersen \| Jack Jr \| Lowe	Cogswell, Petrice
52	Evaluation of [18F]MK6240 test-retest reproducibility for different processing pipelines	Tiss \| Thibault \| Fu \| Becker \| Price \| Johnson	Tiss, Amal
53	Temporal dynamics of tau PET subtypes and its association with heterogeneous neurodegeneration in Alzheimer’s disease	Kwon \| Song \| Lee \| Seong	Kwon, Tae Youn
54	A-T-N-C generative model for predicting and simulating patient-tailored cognitive decline trajectories in Alzheimer’s disease	Lee \| Song \| Kwon \| Lee \| Seong	Kwon, Tae Youn
55	High-resolution ex-vivo MRI reveals layer-specific atrophy of hippocampal subregions to earliest tau pathology	Salman \| Tomé \| Joudiou \| Thal \| Annettesdotter \| Khandelwal \| Yushkevich \| Gallez \| Wisse \| Hanseeuw	Salman, Yasmine
56	Blood volume influences the association between baseline plasma biomarker values and amyloid PET outcomes over time	Burns \| Gogola \| Zeng \| Karikari \| Jacobs \| Lopresti \| Osorio	Burns, Kelsey
57	Visual interpretation methods for tau-PET imaging with Flortaucipir and MK-6240: Insights from the HEAD study	Ruppert \| Vermeiren \| Scop Medeiros \| Povala \| Rocha \| Soares \| Ferreira \| Amaral \| Bauer-Negrini \| Lussier \| Scarpatto Rodrigues \| Oliveira Jr. \| Mroue \| Bellaver \| Moscoso \| Ossenkoppele \| van de Giessen \| Masdeu \| Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Pascoal, Tharick
58	Associations between TSPO PET and CSF and blood-based biomarkers	Smith \| Guzman \| Houlihan \| Sanchez \| Kreisl \| Talmasov \| De Jager \| Herman \| Simoes \| Small \| Lao	Smith, Anna
59	Regional white matter injury modifies the association between ß-amyloid and cognition	Royse \| Reese \| Snitz \| Hengenius \| Crane \| Mukherjee \| Choi \| Willie-Permor \| Felix \| Huppert \| Roush \| Cisneros \| Potopenko \| Lopresti \| Cohen \| Shaaban	Royse, Sarah
60	Sex differences in neuroinflammation, amyloid, tau, and neurodegeneration	Guzman \| Smith \| Houlihan \| Sanchez \| Akinci \| Luchsinger \| Lao	Guzman, Diana
61	Evaluation of the tau PET ligand [18F]florzolotau in frontotemporal dementia	Clarke \| Whittington \| Sholaja \| Hield \| Huiban \| van den Berg \| Margolin \| Rowe \| Rohrer \| Salinas \| Rabiner	Whittington, Alex
62	Intersections of gender/sex and neighborhood deprivation on cognition: Are there mediation effects of Alzheimer's disease biomarkers?	Reese \| Royse \| Snitz \| Crane \| Mukherjee \| Choi \| Hengenius \| Huppert \| Roush \| Cisneros \| Lopresti \| Rameriz Tirado \| Willie-Permor \| Felix \| Cohen \| Shaaban	Reese, Alexandria
63	Disentangling cognitive severity and phenotype across dementia syndromes	Smith \| Coyle-Gilchrist \| Murley \| Rouse \| Stockton \| Naessens \| Savulich \| Wiggins \| Malpetti \| Bowns \| Perquin \| Lanskey \| Karadag \| Kocagoncu \| Quinn \| Pitt \| Alcock \| O'Brien \| Rittman \| Rowe \| Lambon-Ralph	Smith, Viktorija
64	Standardized indices of tau burden using the CenTauR universal scale predict distinct cognitive trajectories across Alzheimer’s disease biological stages	Lopresti \| DelBene \| Leuzy \| Gogola \| Harrison \| Landau \| Jagust \| Villemagne	Lopresti, Brian
65	SPARE-SVD: An integrated machine-learning metric for cerebral small vessel disease within the ATN(V) framework	Dong \| Zhang \| Zeng \| Wang \| Wang \| Toledo \| Gonzales \| Charisis \| Rashid \| Seshadri \| Crane \| Archer \| Jefferson \| Hohman \| Habes	Dong, Mengjin
66	Risk factors and AD prevention: a multivariate and multimodal study	Fajardo Valdez \| Qiu \| Ourry \| Yakoub \| Villeneuve \| Research Group	Fajardo Valdez, Alfonso
67	MK6240 and Tauvid positivity, cognitive decline, and their relationship to Aβ PET deposition across the Alzheimer’s spectrum	Bellaver \| Povala \| Lussier \| Amaral \| Bauer-Negrini \| Ferreira \| Jagust \| Masdeu \| Fortea \| Tudorascu \| Soleimani-Meigooni \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Bellaver, Bruna
68	Differential tau-PET load predominance along shared progression trajectories determines clinical variability in Alzheimer’s disease	Mroué \| Povala \| Bellaver \| Lukasewicz Ferreira \| Bauer-Negrini \| Lussier \| Amaral \| Scop Medeiros \| Ruppert \| Silva da Rocha \| Scarpatto Rodrigues \| Silva Oliveira \| Soares Katz \| Teixeira Leffa \| Saha \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Povala, Guilherme
69	Head-to-head comparison of tau PET tracers across the Alzheimer’s disease spectrum: baseline results from the HEAD study	Povala \| Bellaver \| Lussier \| Amaral \| Bauer-Negrini \| Ferreira \| Jagust \| Masdeu \| Fortea \| Tudorascu \| Soleimani-Meigooni \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Povala, Guilherme
70	Comparison of Sampled Iterative Local Approximation (SILA) implemented in R and MATLAB	Bruzzone \| Coath \| Navaratna \| Carey \| Morse \| Bilgel \| Betthauser	Bruzzone, Hailey
71	Agreement between amyloid status prediction from visual read, SUVR thresholding, and AI-based interpretation of amyloid PET	Peraza \| Joules \| Mohs \| Beauregard \| Dwyer \| Hughes \| Wolz	Wolz, Robin
72	CenTauR thresholds generated using Gaussian Mixture Models for biological staging of amyloid positive ADNI participants	DelBene \| Villemagne \| Gogola \| Leuzy \| Harrison \| Landau \| Jagust \| Lopresti	DelBene, Alexander
73	Progression to tau-PET positivity by plasma P-tau217 levels and its association with clinical decline in preclinical Alzheimer’s disease: data from A4 study	Kim \| Kotari \| Morris \| Shcherbinin \| Yaari \| Holdridge \| Sims \| Ossenkoppele \| Collins \| Hansson \| Lu	Kim, Min Jung
74	Neuroimaging correlates of loneliness	Sanchez \| Guzman \| Smith \| Houlihan \| Stern \| Bockting \| Lao	Sanchez, Thairi
75	Age-dependent associations between salivary inflammatory cytokines and amyloid-beta in cognitively unimpaired older adults	Parker \| Tang \| Taylor \| Bock \| Meza \| Tuteja \| Avila \| Chang \| Simmons \| Bamford \| Yi \| Mcmillan \| Kim \| Thomas \| Adams \| Yassa	Parker, Dana
76	Tau accumulation drives worsening depressive symptoms in cognitively normal older adults	Markova \| Berry	Markova, Teodora
77	Dorsal raphe nucleus and locus coeruleus differentially relate to depressive symptoms in cognitively normal older adults	Markova \| Chen \| Carlson \| Cao \| Ciampa \| Marcus \| Adornato \| Matulonis \| Morin \| Hooker \| Berry	Markova, Teodora
78	Evaluating occipital-to-global amyloid PET as a predictor of CAA at autopsy in Mayo Clinic cohorts	Schwarz \| Hu \| Cogswell \| Graff-Radford \| Vemuri \| Przybelski \| Wiste \| Nguyen \| Reichard \| Dickson \| Lowe \| Ramanan \| Knopman \| Petersen \| Jack	Schwarz, Christopher
79	SCAN: Standardized Centralized Alzheimer’s and related dementias Neuroimaging	Schwarz \| Harrison \| DeCarli \| Kantarci \| Baker \| La Joie \| Maillard \| Rabinovici \| Toga \| Jack \| Jagust	Schwarz, Christopher
80	Differential contributions of amyloid spatial extent and tau burden to domain-specific cognitive decline in early Alzheimer’s disease	Slade \| Thibault \| Thompson \| Fanglu Fu \| Price \| Rentz \| Sperling \| Johnson \| Farrell	Slade, Elliott
81	PET-measured amyloid accumulation rate modulates tau accumulation rate in individuals with Down syndrome	Bettcher \| McLachlan \| Zammit \| McVea \| Betthauser \| Laymon \| Tudorascu \| Cohen \| Price \| Head \| Mapstone \| Lao \| Johnson \| Ances \| Handen \| Christian	Bettcher, Brecca
82	Elevated medial temporal lobe tau predicts cross-sectional association between neocortical tau and global amyloid burden	Thibault \| Reilhac-Laborde \| Charil \| Irizarry \| Johnson	Thibault, Emma G.
83	Assessing the effect of amyloid status on the relationship between glucose metabolism and synaptic density in the aging population	McLachlan \| Bettcher \| DiFilippo \| LeMerise \| McVea \| Zammit \| Langhough \| Johnson \| Bendlin \| Christian	McLachlan, Max
84	Associations between p-tau217 and brain atrophy are amplified by Aβ burden and APOEε4	Brown \| Properzi \| Cuppels \| Birkenbihl \| Coughlin \| Seto \| Townsend \| Betthauser \| Schultz \| Chhatwal \| Yang \| Jacobs \| Farrell \| Johnson \| Johnson \| Li \| Sperling \| Hohman \| Donohue \| Buckley	Brown, Jane
85	Early cortical thickness change in preclinical AD development	Sinclair \| Chen	Sinclair, Stephanie
86	Immuno-vascular crosstalk drives tau pathology preferentially in women	Wood Alexander \| Kang \| Rusdi \| Yin \| Rahmouni \| Wang \| Benedet \| Zetterberg \| Blennow \| Karikari \| Ashton \| Black \| Goubran \| Rabin \| Ottoy	Wood Alexander, Madeline
87	Midlife physical activity attenuates the association of earlier menopause with tau pathology and cognitive decline	Wood Alexander \| Cadwallader \| Johnson \| Casaletto \| Rabin	Wood Alexander, Madeline
88	Improved tau PET signal detection with total-body PET compared to conventional PET: A preliminary study	Young \| Bayerlein \| Bhattarai \| DeCarli \| Badawi \| Fan	Young, Christina
89	Demographic associations with plasma biomarkers in the oldest-old: The LifeAfter90 Study	Young \| Colbeth \| Gilsanz \| Corrada \| Rizvi \| Zhou \| di Lucente \| DeCarli \| Jin \| Whitmer	Young, Christina
90	Differential sensitivity of T1-MRI and FDG-PET for tracking neurodegeneration across progressive stages of tau pathology in Alzheimer’s disease	Vourkas \| Karagianni \| Moscoso \| Zhang \| Sanchez-Juan \| Schöll \| Grothe \| Silva-Rodríguez	Silva-Rodríguez, Jesús
91	SPARE-Tau, a machine-learning derived tau-PET index, correlates with Alzheimer's disease and related dementias biomarkers	Wang \| Zeng \| Toledo \| Gonzales \| Honnorat \| Charisis \| Dong \| Ho \| Rashid \| Kutty \| Salman \| Vroman \| Seshadri \| Habes	Wang, David
92	Assessing the generalizability of plasma p-tau217 cutpoints for amyloid-β detection across clinical and preclinical cohorts	Liu \| Zeng \| Nafash \| Sehrawat \| Choity \| Gu \| Farinas \| Bedison \| Matan \| Gogola \| Huang \| Sewell \| McAuley \| Hillman \| Kramer \| Burns \| Kang \| Vidoni \| Nadkarni \| Aizenstein \| Kofler \| Tudorascu \| Shaaban \| Lingler \| Pascoal \| Villemagne \| Berman \| Sweet \| Snitz \| Ikonomovic \| Kamboh \| Erickson \| Cohen \| Lopez \| Deek \| Karikari	Liu, Tianshu
93	Evaluating the transferability of dual cutpoints for plasma p-tau217 in detecting brain amyloid-β across diverse cohorts	Liu \| Zeng \| Nafash \| Sehrawat \| Choity \| Gu \| Farinas \| Bedison \| Matan \| Gogola \| Huang \| Sewell \| McAuley \| Hillman \| Kramer \| Burns \| Kang \| Vidoni \| Nadkarni \| Aizenstein \| Kofler \| Tudorascu \| Shaaban \| Lingler \| Pascoal \| Villemagne \| Berman \| Sweet \| Snitz \| Ikonomovic \| Kamboh \| Erickson \| Cohen \| Lopez \| Deek \| Karikari	Liu, Tianshu
94	Free-water interacts with amyloid positivity to predict regional tau pathology in both early and late Braak stages	Sathe \| Durant \| Koran \| Dumitrescu \| Cody \| Sokołowski \| Kim \| Mez \| Saykin \| Toga \| Cuccaro \| Tosun \| Johnson \| Barber \| O'Bryant \| Landman \| Mormino \| Hohman \| Archer	Sathe, Aditi
95	Integration of data-driven biomarker discovery with established Alzheimer’s disease biomarkers in an African American cohort	Kuchenbecker \| Heckman \| Nguyen \| Casellas \| Sotelo \| Schwarz \| Senjem \| Jain \| Lucas \| Willis \| Ertekin-Taner \| Graff-Radford \| Kantarci \| Lowe \| Lachner \| Day \| Carrasquillo	Kuchenbecker, Lindsey
96	Early concordance between Aβ PET spatial extent and plasma %ptau217	Farrell \| Thibault \| Yang \| Price \| Chhatwal \| Coughlan \| Buckley \| Sperling \| Johnson	Farrell, Michelle

POSTER SESSIONS: 3A - Wednesday, January 14, 10:35 - 11:35 am; 3B - Wednesday, January 14, 2:45 - 3:45 pm

Board #	Title	Authors	Presenter
97	Longitudinal trajectories of plasma p-tau217 across multiple assays in relation to amyloid and tau PET and cognition	Shekari \| Tosun \| Dage \| Schindler \| Shaw \| Jagust \| Landau	Shekari, Mahnaz
98	The relation of psychosocial coping mechanisms to ATN pathophysiology differ across demographics.	Schatz \| Snitz \| Roush \| Lopresti \| Villemagne \| Lopez \| Williams \| Cohen	Williams, Lilcelia A.
99	Intermediate blood-based biomarker status clarified by PET and CSF in cognitively impaired individuals	Ziontz \| Blazhenets \| Lin \| Landau \| Shaw \| Dage \| Hammers \| Eloyan \| Koeppe \| Carillo \| Dickerson \| Rabinovici \| La Joie	Ziontz, Jacob
100	Operationalizing clinical criteria for LATE using cognitive, MRI, and AD biomarker (biofluid or PET) data	Cuppels \| Birkenbihl \| Schneider \| Bennett \| Brown \| Seto \| Coughlan \| Li \| Townsend \| Properzi \| James \| Arfanakis \| Sperling \| Yang \| Chhatwal \| Amariglio \| Hohman \| Donohue \| Buckley	Cuppels, Madison
101	CT-based processing is equivalent to MR-based processing for tau PET regional quantification	Povala \| Bellaver \| Amaral \| Lussier \| Ferreira \| Bauer-Negrini \| Tudorascu \| Masdeu \| Fortea \| Soleimani-Meigooni \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Povala, Guilherme
102	A pilot study on the association of plasma proteins with neuroimaging biomarkers of Alzheimer’s disease in African Americans	Arowolo \| Kuchenbecker \| Heckman \| Nguyen \| Casellas \| Sotelo \| Schwarz \| Senjem \| Jain \| Lucas \| Willis \| Ertekin-Taner \| Graff-Radford \| Kantarci \| Lowe \| Lachner \| Day \| Carrasquillo	Arowolo, Olatunbosun
103	Amyloid-PET and white matter hyperintensities but not military service duration nor combat exposure are associated with neurodegeneration and cognitive impairment in older veterans	Rocha \| Pasternak \| Lesman Segev \| Schwartz \| Blazhenets \| Maiti \| Rosen Lang \| Hantke \| Livny-Ezer \| Yaffe \| Shaw \| Weiner \| Hills \| Kritikos \| Soleimani-Meigooni \| Silbert \| La Joie \| Gardner	Rocha, Salma
104	The influence of cardiovascular risk on white matter integrity along the Alzheimer’s disease trajectory: Early impact in preclinical stages	Edison \| Arnold	Edison, Paul
105	Longitudinal tau PET progression follows language network spread in primary progressive aphasia	Martersteck \| Rogalski	Martersteck, Adam
106	The adjusted Centiloid: Improving reliability by correcting for white matter uptake variability	Reilhac \| Irizarry \| Reyderman \| Charil	Reilhac, Anthonin
107	Perivascular spaces: Predictors of longitudinal amyloid, tau, cerebrovascular biomarkers?	Low \| Gunter \| Hu \| Raghavan \| Przybelski \| Schwarz \| Kantarci \| Lowe \| Graff-Radford \| Petersen \| Jack \| Vemuri	Low, Audrey
108	Longitudinal evaluation of neuroinflammation using 11C-ER176 TSPO PET	Lim \| Cogswell \| Min \| Lee \| Brunn \| Kandimalla \| Jacobson \| Nycklemoe \| Lee \| Lundt \| Botha \| Graff-Radford \| Jones \| Vemuri \| Kantarci \| Jack \| Petersen \| Lowe	Lim, Seokbeen
109	Comparison of meningeal signal between [¹⁸F]AV-1451 and [¹⁸F]MK-6240 tau PET using a distance-based meningeal mask	Lim \| Gunter \| Baker \| Tissot \| Brunn \| Soleimani-Meigooni \| Oh \| Fortea \| Pascual \| Gordon \| Rosa-Neto \| Pascoal \| Klunk \| Jagust \| Senjem \| Botha \| Knopman \| McCarter \| Ramanan \| Graff-Radford \| Schwarz \| Kantarci \| Boeve \| Vemuri \| Jones \| Jack \| Petersen \| Lowe	Lim, Seokbeen
110	Effects of regional tau accumulation on visual discrimination of novel objects in clinically unimpaired older adults	Kapadia \| Medina Guerra \| Sai \| Bonnen \| Wagner \| Mormino \| Trelle	Kapadia, Dhruv
111	Key quantitative benchmarks with CenTauR in cross-sectional and longitudinal large datasets	Dore \| Bourgeat \| Betthauser \| Feizpour \| Moscoso \| Leuzy \| Fripp \| Johnson \| Rowe \| Villemagne	Villemagne, Victor
112	Astrocytic reactivity is related to synchronization of regional amyloid-beta deposition	Adams \| Parker \| Taylor \| Tang \| Meza \| Tuteja \| Avila \| Chang \| Simmons \| Malhas \| Kim \| McMillan \| Mapstone \| Yassa	Adams, Jenna
113	Synergistic effects of amyloid-beta and hyperexcitability on tau pathology and cognitive decline	Vanderlip \| Adams	Adams, Jenna
114	Amyloid does not discriminate: a meta-analysis of sex differences in Centiloids from 35,468 participants across 33 cohorts	Blazhenets \| Pezzoli \| Casaletto \| Soleimani-Meigooni \| Chiotis \| Allen \| Rabinovici \| La Joie \| Study Group	Blazhenets, Ganna
115	Preliminary associations of plasma phosphorylated tau217 with regional tau deposition and accumulation in medial temporal and neocortical regions	Pintucci \| Thibault \| Farrell \| Yang \| Chhatwal \| Properzi \| Becker \| Price \| Sperling \| Johnson	Pintucci, Eva
116	Contrasting neuropathology- and tau PET-based Braak stage associations with dementia severity to clarify differences between radiologic and pathologic findings	Evelhoch \| Bruzzone \| Rocha \| Asthana \| Nirschl \| Johnson \| Schneider \| Hyman \| Pascoal \| Betthauser	Evelhoch, Jeffrey
117	Novel pet tracer [11C]-CS1P1 uptake reflects decreased sphingosine-1-phosphate receptor 1 activity in vivo in Alzheimer’s disease and related dementias	Tiemann Powles \| Friedrichsen \| Flores \| Rajamanickam \| Keefe \| Simmons \| Doering \| McKay \| Hoagey \| Sabaredzovic \| Ibanez \| Morris \| An \| Brier \| Tu \| Benzinger	Tiemann Powles, Savannah
118	Digital maze test reveals features related to cortical tau in cognitively normal Aβ+ older adults	Robinson \| Fu \| Amariglio \| Sperling \| Johnson \| Davis \| Penney \| Rentz	Robinson, Talia
119	Associations of regional neuroinflammation by ER176 PET SUVR with cognitive scores	Jacobson \| Lim \| Lundt \| Nycklemoe \| Min \| Botha \| Graff-Radford \| Jones \| Vemuri \| Kantarci \| Knopman \| Jack \| Petersen \| Lowe	Jacobson, David
120	Cluster-based metric of early tau-PET aggregation is associated with plasma p-tau217 in cognitively unimpaired older adults with subthreshold amyloid-beta	Varghese \| Brock \| Taylor \| Thomas \| Yassa \| Adams	Varghese, Leah
121	Sex differences in regional Aβ burden are associated with decreased cingulum integrity uniquely in older cognitively unimpaired women	Yi \| Parker \| Tang \| Taylor \| Tuteja \| Meza \| Avila \| Chang \| Simmons \| Bamford \| McMillan \| Kim \| Thomas \| Adams \| Yassa	Yi, Emily
122	Cerebral vessel morphology is associated with white matter lesions burden	Huang \| Li \| Rocha \| Stetten \| Yang \| Ibrahim \| Wu \| Aizenstein	Huang, Yuanzhe
123	Early ventral temporal tau burden marks functional vulnerability in aging	Sheng \| Trelle \| Sai \| Young \| Romero \| Park \| Vossler \| Younes \| Davidzon \| Wagner \| Mormino	Sheng, Jintao
124	Alignment of antemortem images to postmortem fixed hemibrains using standard neuroimaging tools	Coath \| Staruck \| Carey \| de Chavez \| Karas \| Abrahamson \| Asthana \| Johnson \| Ikonomovic \| Nirschl \| Betthauser	Coath, William
125	Towards a harmonized amyloid clock: centralized image processing and temporal modeling with multiple cohorts and tracers	Coath \| Bruzzone \| Morse \| Navaratna \| Hammond \| Staruck \| Nowinski \| Palmer \| Kelley \| Schwartz \| Carey \| Betthauser	Coath, William
126	Cluster-based MK-6240 PET detects early neocortical temporal tau spread	Thompson \| Becker \| Fanglu Fu \| Farrell \| Thibault \| Slade \| Sperling \| Price \| Johnson	Thompson, Jackson
127	Gaussian smoothing and partial volume correction modify relationships of tau burden with biological variables in longitudinal multi-site studies of 18F-Flortaucipir PET	Luo \| Laymon \| Baker \| Cohen \| Villemagne \| Lopresti \| Aizenstein \| Tudorascu \| Minhas	Luo, Weiquan
128	No detectable association between BDNF Val66Met and hippocampal volume or regional tau PET in ADNI after propensity score matching and ComBat harmonization	Han \| Minhas \| Laymon \| Villemagne \| Tudorascu	Han, Yushui
129	Centiloid and SUVR amyloid harmonization techniques comparisons for head-to-head unequally spaced data	Han \| Lopresti \| Bourgea \| Laymon \| Villemagne \| Tafti \| Minhas \| Tudorascu	Han, Yushui
130	Plasma amyloid beta 42/40 modifies the associations between MRI biomarkers and subsequent cognitive impairment: a neuroimaging-wide longitudinal study in the BLSA	Duran \| Bilgel \| An \| Kandala \| Davatzikos \| Landman \| Erus \| Ferrucci \| Moghekar \| Walker \| Resnick	Duran, Tugce
131	High-resolution NAV template using the Siemens Biograph Vision	Bourgeat \| Rowe \| Paranawithana \| Feizpour \| Huang \| Villemagne \| Fripp \| Dore	Rowe, Christopher
132	Higher clinical throughput quantitative amyloid-β PET using abbreviated acquisition windows	Paranawithana \| Gillman \| Bourgeat \| Fripp \| Villemagne \| O’Keefe \| Huang \| Benzinger \| LaMontagne \| Morris \| Doré \| Rowe	Rowe, Christopher C.
133	Tracer-specific effects of hormone replacement therapy on age-related tau accumulation	Tissot \| Shi \| Tsai \| Maboudian \| Fonseca \| Rahmouni \| Lussier \| Therriault \| Trudel \| Cassa Macedo \| Stevenson \| Bellaver \| Ferreira \| Povala \| Gordon \| Pascual \| Lowe \| Soleimani-Meigooni \| Oh \| Klunk \| Rosa-Neto \| Jagust \| Buckley \| Pascoal \| Baker	Tissot, Cécile
134	Cognitive and age-related differences in low-tau individuals assessed with [18F]FTP and [18F]MK6240	Tissot \| Shankar \| Tsai \| Rahmouni \| Lussier \| Therriault \| Trudel \| Cassa Macedo \| Stevenson \| Bellaver \| Ferreira \| Povala \| Gordon \| Pascual \| Lowe \| Soleimani-Meigooni \| Oh \| Klunk \| Rosa-Neto \| Jagust \| Landau \| Pascoal \| Baker	Tissot, Cécile
135	Integration of network analysis of the plasma proteome with Alzheimer's disease neuroimaging outcomes in an African American cohort	Hurst \| Kuchenbecker \| Heckman \| Nguyen \| Casellas \| Sotelo \| Shwarz \| Senjem \| Jain \| Lucas \| Willis \| Ertekin-Taner \| Graff-Radford \| Kantarci \| Lowe \| Lachner \| Day \| Carrasquillo	Hurst, Cheyenne
137	MK6240 and Flortaucipir Braak staging agreement in a head-to-head cohort	Rocha \| Soares \| Ruppert \| Medeiros \| Bellaver \| Povala \| Ferreira \| Bauer-Negrini \| Lussier \| Tudorascu \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Pascoal, Tharick
138	Comparing neuropathologic and tau-PET Braak staging across clinical progression using MK6240 and flortaucipir	Rocha \| Bruzzone \| Ruppert \| Medeiros \| Soares \| Bellaver \| Povala \| Ferreira \| Lussier \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Johnson \| Evelhoch \| Betthauser \| Pascoal	Pascoal, Tharick
139	Predictors of data exclusion in MR-dependent imaging analyses of Alzheimer disease	Flores \| Scott \| Lu \| Su \| Keefe \| Smith \| Hornbeck \| McKay \| Strain \| Simmons \| Dombrowski \| Rizzo \| Shimony \| Bateman \| Babulal \| Landau \| Jagust \| Wolk \| Lah \| Gleason \| Johnson \| Roberson \| Sperling \| Johnson \| Morris \| Xiong \| Gordon \| Benzinger	Flores, Shaney
140	Brain network architecture shapes the pattern of tau-induced neuronal dysfunction in Alzheimer's disease, while tau load drives local damage	Frontzkowski \| Roemer-Cassiano \| Gnörich \| Dewenter \| Steward \| Zhu \| Klonowski \| Hirsch \| Biel \| Palleis \| Höglinger \| Brendel \| Franzmeier	Frontzkowski, Lukas
141	Cortical thickness and female sex confer resilience to tau-related cognitive decline: A large multi-cohort study	Mitchell	Mitchell, Stuart
142	Structure-guided design of 18F-FD4—a PET tracer of α-synuclein fibrils	Liu \| Li \| Wang \| Zuo \| Tan \| Bian \| Fan \| Liang	Qing, Liang
143	NULISAseq CNS proteomic signatures of astrocytic reactivity in Alzheimer’s disease	Shi \| Zeng \| Balogun \| Farinas \| Lopresti \| Gogola \| Ikonomovic \| Aizenstein \| Villemagne \| Cohen \| Karikari	Shi, Ruyu
144	High p-tau217 levels nullify the slower cognitive progression in younger older adults	Shi \| Choity \| Brodman \| Zeng \| Deek \| Gu \| Farinas \| Nafash \| Bedison \| Mercurio \| Matan \| Gogola \| Kofler \| Tudorascu \| Nadkarni \| Aizenstein \| Shaaban \| Lingler \| Pascoal \| Villemagne \| Berman \| Sweet \| Snitz \| Ikonomovic \| Cohen \| Kamboh \| Lopez \| Karikari	Shi, Ruyu